SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001062993-23-012828
Filing Date
2023-06-02
Accepted
2023-06-02 20:53:42
Documents
1
Period of Report
2023-05-31

Document Format Files

Seq Description Document Type Size
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.html 4  
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.xml 4 3920
  Complete submission text file 0001062993-23-012828.txt   5464
Mailing Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404
Business Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404 6504737700
GERON CORP (Issuer) CIK: 0000886744 (see all company filings)

IRS No.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O REATA PHARMACEUTICALS, INC. 2801 GATEWAY DRIVE, SUITE 150 IRVING TX 75063
Business Address
Bir Dawn Carter (Reporting) CIK: 0001688712 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-20859 | Film No.: 23991011